Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
about
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumoursLoss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancerAPRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancerPioneer transcription factors: establishing competence for gene expressionIdentification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cellsEpigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancersAssociation of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancerGene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB familyFOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway.Enumerating the gene sets in breast cancer, a "direct" alternative to hierarchical clustering.Genome profiling of ERBB2-amplified breast cancers.Discovery of pathway biomarkers from coupled proteomics and systems biology methodsCooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor developmentPBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.Loss of ERα and FOXA1 expression in a progression model of luminal type breast cancer: insights from PyMT transgenic mouse model.A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer.Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor.FOXA1 in breast cancer.FOXA1: master of steroid receptor function in cancer.Co-modulation analysis of gene regulation in breast cancer reveals complex interplay between ESR1 and ERBB2 genesLow FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases.Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancerFOXA1 represses the molecular phenotype of basal breast cancer cellsFoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growthClinicopathological significance of forkhead box protein A1 in breast cancer: A meta-analysis.Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer.FOXA1: a transcription factor with parallel functions in development and cancer.FOXA2 mRNA expression is associated with relapse in patients with Triple-Negative/Basal-like breast carcinoma.Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells.FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer.A novel FOXA1/ESR1 interacting pathway: A study of Oncomine™ breast cancer microarrays.TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells.Paradoxical roles for FOXA1 in anti-estrogen resistance and as a luminal differentiation factor in breast cancer.FOXA1 is an independent prognostic marker for ER-positive breast cancer.Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores.Expression and relevance of TRPS-1: a new GATA transcription factor in breast cancer.Pioneer transcription factors shape the epigenetic landscape.
P2860
Q21030553-60A5BC25-CF87-4A8F-97D2-EBA5890898C2Q24299591-25359467-7DD0-449E-9B2F-53ED20664EE2Q24304176-4B732FE7-FD93-4A99-97C0-8C653D635D8CQ24625373-91F44BB4-5B22-496D-979B-A5F599F5A87CQ24626014-A45CAEF2-5B6C-4F18-97A6-DC9F5A4F7742Q24630926-43469347-F334-44FF-A941-C13186721050Q24653339-65871D0E-D6E7-4635-843B-4F5203C5780CQ28258227-F0B0B28F-BAC2-4796-848E-381A8E744DA7Q31083556-862FCDB1-69AD-4716-91A8-4AB6542C823FQ33669571-07A9BDCE-7AA0-4E00-BEAB-E6EFF9C19F79Q33713239-81AEA166-D328-467A-98D8-B4346B14492EQ33737009-FB4211EF-1AE3-4C2C-8BE3-E3263F1CD431Q34048129-0BC37059-ABF4-46DD-95BD-2DA9C891D59CQ34085622-45ACFB20-4A62-4B40-BDE4-49A174AC4B54Q34167687-512D7540-963E-4060-83A7-1773E1B1E304Q34577709-D5E68FD4-6F93-4EA3-A323-1D17896B9D84Q34689061-CCA374D6-D5DC-45A5-AFB9-7824989558C1Q34956469-22D728E4-B59E-4D3A-80E9-D471B0538DD6Q35532767-E6DF5EE5-D380-46A7-93C2-D7A7FF820DC9Q35671323-96095F42-3555-4772-A0B6-3FDF866B27CBQ35677301-A1C96242-F8C5-43A8-9FF3-5132C2B51210Q35949760-44F24554-C113-409E-A239-6FE04F859642Q36020557-15807011-93E1-4F28-BB4F-27394E2ED6FCQ36768822-BA07668F-0182-42DE-94E5-F06CBEF39ACDQ36953276-03C9DFAA-4A5D-457F-83E8-12E6C913DFAEQ37643951-514E3B0F-35D8-4FC1-99DE-298025F580BCQ37688280-C5CCE7D2-D40E-4B12-8969-99BA80E9081CQ37960622-3030ACB7-AD40-41DE-9D6A-2D5D45B7B678Q38841683-55FC0CD6-300A-40CC-B323-B2FA2D53C414Q38975595-EF794A4D-105E-4941-9CDC-40BDF2B883E1Q39400129-C3B95A4B-336D-4387-9865-37AAAFA9B1BFQ39588969-4FE8B5B9-633C-4C02-B877-FC1232EDBD95Q40090503-280352B3-FE4D-40DA-ABEA-BF859D275D2FQ41598833-4A00F387-8094-43B3-8557-EA5D4F7DFF47Q41926547-01B67DCE-FA06-4B1D-A101-B7A074B8C53BQ42199542-4277B38E-CDD5-4C41-AFD3-5C3D89CF072CQ42486962-7040BE95-7E6F-4A18-8343-5C675BCB529EQ43234010-FAF0585D-3025-48DD-8EC0-AE83092C7066Q45918558-E293E9F3-47AC-4A3B-8C21-AA9B7EA5E32BQ50532548-7E66BD9B-9DCC-44CC-A3A0-442621F90010
P2860
Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Forkhead box A1 expression in ...... al subtype and good prognosis.
@en
Forkhead box A1 expression in ...... al subtype and good prognosis.
@nl
type
label
Forkhead box A1 expression in ...... al subtype and good prognosis.
@en
Forkhead box A1 expression in ...... al subtype and good prognosis.
@nl
prefLabel
Forkhead box A1 expression in ...... al subtype and good prognosis.
@en
Forkhead box A1 expression in ...... al subtype and good prognosis.
@nl
P2093
P356
P1476
Forkhead box A1 expression in ...... nal subtype and good prognosis
@en
P2093
P304
P356
10.1136/JCP.2007.052431
P407
P577
2007-11-23T00:00:00Z